Carey Advises Chilean Biotechnology Company Phage Technologies in Equity Round of Financing for US$30 Million
June, 2021 - Chile
Carey served as local counsel to Phage Technologies in the second round of equity financing for the company, after a seed round financing in 2018, in which Invexor Capital, a Chilean-based investment firm that invests in private equity and venture capital companies, participated.
Among the new investors in this round are Kaszek Ventures, one of the largest venture capital firms in Latin America with nine unicorns in its portfolio, and Humboldt Fund, an investment firm that seeks to invests in revolutionary biotechnology companies in their early stages.
Phage Technologies is a biotechnology company that develops bacteriophage applications to improve intensive breeding processes.
In-House:
María Loreto Villalón, Legal Counsel
[email protected]
Carey
Local Counsel to Phage Technologies:
Francisco Guzmán, Partner
[email protected]
Constanza Rivera, Associate
[email protected]
Andrés Latorre, Associate
[email protected]
Wilson Sonsini Goodrich & Rosati
Counsel to Phage Technologies in USA:
Matt Squires, Partner
[email protected]
Kiri Yoshimura, Venture Counsel
[email protected]
Magliona Abogados
Local Counsel to Kaszek Ventures:
Claudio Magliona, Partner
[email protected]
Carolina Abarca, Counsel
[email protected]
Gunderson Dettmer
Counsel to Kaszek Ventures in USA:
Brian C. Hutchings, Partner
[email protected]
Daniel Gallo, Associate
[email protected]
